Patients with cystic fibrosis in Spain may have a lower incidence of COVID-19 as well as lower associated mortality compared with the general population.
The COVPN is part of “Operation Warp Speed”, a partnership led by the Department of Health and Human Services to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.
Conducting point-prevalence surveys in skilled nursing facilities can inform infection prevention and control activities to reduce COVID-19 transmission.
Self-assessment tool could ease burden on the healthcare system and collect useful information.
A phase 3 trial evaluating an investigational antiviral antibody cocktail, REGN-COV2, for the prevention of COVID-19 has been initiated by Regeneron Pharmaceuticals.
The rate of patients who required mechanical ventilation and died was similar between patients with HIV and matched comparators.
Siltuximab is currently marketed under the trade name Sylvant and is indicated for the treatment of multicentric Castleman’s disease.
Recommendations by ASAIO on selection and treatment of patients with respiratory and circulatory failure associated with COVID-19 using artificial pulmonary and/or cardiac support.